AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04320940 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Phenobarbital Sodium Injection
Description: The initial dose will be administered intravenously over a 30-minute period. The time period between the first and second dose of phenobarbital cannot occur within 30 minutes of the end of the first dose.
Study NCT04520425 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Osteopathic manipulative therapy
Description: 1. Mandibular: the clinician applies gentle pressure bilaterally to the subject's mandible, in the direction of the patient's clavicles.~2. Frontal: the clinician applies gentle pressure bilaterally to the subject's forehead, in a direction halfway between the parietals and ears.~3. Temporal: the clinician applies gentle pressure bilaterally to the subject's temples, in the direction of the patient's occiput.~4. Parietal: the clinician applies gentle pressure bilaterally to the subject's parietal bones, in the direction of the patient's occipital atlanto joint.~5. Occipital: the clinician applies gentle pressure to the subject's occipital bone, in the direction of the patient's neck.
Study NCT05581212 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tuberculosis Case-Finding, Treatment and Prevention Public Health Pack
Description: Combined active case-finding, treatment and prevention of TB amongst HH contacts of TB cases, associated with initiation of standard of care (SOC) treatment in active TB cases and initiation of TB preventive therapy in those contacts without active TB, based on free screening. This intervention will be compared to the standard of care available in the country.
Study NCT05894850 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: AI based automatic surveillance (AS) system (ENDOANGEL-AS) reminds the patients through by telephone .
Description: An automatic surveillance (AS) system to accurately identify post-polypectomy patients, assign surveillance intervals for different risks of patients and proactively follow up with patients at certain times. AI based automatic surveillance (AS) system (ENDOANGEL-AS) reminds patients by telephone.
Study NCT05894850 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: AI based automatic surveillance (AS) system (ENDOANGEL-AS) reminds the patients through message.
Description: An automatic surveillance (AS) system to accurately identify post-polypectomy patients, assign surveillance intervals for different risks of patients and proactively follow up with patients at certain times. AI based automatic surveillance (AS) system (ENDOANGEL-AS) reminds patients through message.
Study NCT06537973 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: İndividualized care education
Description: A single session of training will be given to the mothers in the experimental group. In addition, the mother will be provided with counseling by the researcher at any time she wishes. The aim is to increase the mother-infant bonding levels and self-efficacy of the mothers, who will be supported by the care plans that will be created based on Swanson\&#39;s Theory of Care, and to adapt more easily to the role of motherhood, by evaluating them with the help of check-lists after the observations.
Study NCT05894850 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Manually remind the patients
Description: Medical staff remind patients manually .
Study NCT05408663 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EXT608
Description: EXT608 is an investigational drug administered via subcutaneous injection
Study NCT05408663 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: matching placebo administered via subcutaneous injection
Study NCT05321303 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Serious Game
Description: Each participant of the Serious game group played 1 scenario of MetaHospital, a screen-based simulation on the management of diabetic ketoacidosis. Immediately after the serious game was played, 5 open-ended questionnaires were sent to the students to evaluate the game usability.
Study NCT05321303 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard Patients
Description: Each participant of the standardized patient's group played 1 scenario on the management of diabetic ketoacidosis and then a 30-minute analysis session with the trainer joined.
Study NCT05444309 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Quadratus lumborum (QL) block group
Description: patient will receive 0.5 mg/kg of bupivacaine 0.25% through the quadratus lumborum block approach
Study NCT05444309 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Pericapsular Nerve Group (PENG) block group
Description: patient will receive 0.5 mg/kg of bupivacaine 0.25% through the Pericapsular Nerve Group (PENG) block
Study NCT06265376 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Educational Video
Description: A recorded educational video will be presented to the patient prior to meeting with the provider at the presurgical meeting
Study NCT05857163 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rifasutenizol placebo capsules
Description: BID
Study NCT04975646 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Prescribed exercise program
Description: Active or passive exercises for the spastic upper limb, including functional electrical stimulation (FES), performed regularly for two weeks.
Study NCT05114603 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HLX208
Description: level 1:600mg po Bid level 2:900mg po Bid
Study NCT06251713 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: VeXUS score guided fluid management strategy
Description: During the first 3 postoperative days, the VeXUS score is estimated daily by ultrasound. If VeXUS score >1, diuretic-induced fluid removal will be administred (target diuresis: 2-4mL/kg/h). The diuretic administration protocol is derived from the CARRESS HF study: bolus followed by a continuous administration of Furosemide with thiazide added based on preoperative diuretic administration status.~To prevent hypokalaemia and dysnatremia, a protocol for potassium supplementation and intravenous administration of chloride serum or hypotonic perfusion is planned.~Fluid removal will be suspended if severe metabolic disturbance (pH>7.55 with HCO3->40mmol/L or serum K+ \<3 mmol/L or serum Na>150 mmol/L) or haemodynamic instability (hypoperfusion) with fluid responsiveness occurs. Regardless of the VeXUS score, diuretics will be introduced in case of pulmonary oedema.~Haemodynamic status will be every 12 hours to detect side effects attributable to diuretic-induced fluid removal.
Study NCT06251713 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Usual care
Description: Fluid management will be at the discretion of attending physician, who will be blinded to the patient's VeXUS score status.
Study NCT03762603 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Robotic exoskeleton device
Description: It is a non invasive and non significant risk medical device which wraps around operated knee to support motion.
Study NCT06539468 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Best Practice
Description: Receive SOC treatment
Study NCT06539468 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Educational Activity
Description: Watch an educational video on AS for LR-BCC
Study NCT06539468 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Patient Observation
Description: Undergo active surveillance
Study NCT06539468 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Survey Administration
Description: Ancillary studies
Study NCT06539468 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Survey Administration
Description: Ancillary studies
Study NCT06049758 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: LAPAROSCOPIC RIGHT HEMICOLECTOMY procedure (intervention)
Description: Patients with right-side colon cancer (caecum, ascending, or hepatic flexure); were diagnosed by CT entero-colonography, colonoscopy, and biopsy who undergo laparoscopic right hemicolectomy
Study NCT06049758 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Enoxaparin 40 Mg/0.4 mL Injectable Solution
Description: Enoxaparin sodium 40 mg subcutaneous injection will be administered 12 hours before the operation
Study NCT06049758 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Levofloxacin 500mg
Description: Levofloxacin 500 mg intravenous injection will be administered 1 hour before the operation.
Study NCT06049758 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: LAPAROSCOPIC RIGHT HEMICOLECTOMY procedure (Conventional)
Description: Patients with right-side colon cancer (caecum, ascending, or hepatic flexure); were diagnosed by CT entero-colonography, colonoscopy, and biopsy who undergo laparoscopic right hemicolectomy
Study NCT06139913 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: aerobic exercise
Description: moderate intensity aerobic exercise using treadmill
Study NCT05689840 — intervention group
Intervention type: PROCEDURE
Intervention: Receiving inpatient surgical intervention
Description: Receiving inpatient surgical intervention in Peking Union Medical College Hospital
Study NCT05473533 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo; formulated as solution for inhalation without active substance.
Study NCT05473533 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PRS-220
Description: PRS-220; formulated as solution for inhalation.
Study NCT06402188 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ColoSeal ICD Device
Description: The subject will undergo scheduled resection per the surgeon's preferred technique. Following completion of the anastomosis, the Intraluminal Colonic Diversion (ICD) Device will be inserted, advanced and positioned with the ICD Delivery System transanally. The ICD Device will remain in place for 10± 2 days. Anastomotic leak testing will be performed prior to scheduled removal.
Study NCT06224530 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Levetiracetam
Description: Single dose of 500mg levetiracetam The capsules of levetiracetam and placebo will be visibly the same.
Study NCT06224530 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Single dose of 75mg ascorbic acid. The capsules of levetiracetam and placebo will be visibly the same.
Study NCT05402943 — intervention group
Intervention type: BEHAVIORAL
Intervention: Nursing Care Program for Endometriosis
Description: Nursing Care Program for Endometriosis, developed in line with Health Promotion Model
Study NCT05402943 — intervention group
Intervention type: BEHAVIORAL
Intervention: EHP-5 Endometriosis Health Promotion Model.
Description: EHP-5 Endometriosis Health Promotion Model. A questionnaire used to measure the quality of life of women with endometriosis
Study NCT05402943 — intervention group
Intervention type: BEHAVIORAL
Intervention: Healthy Life Style Behaviours Scale II.
Description: A questionnaire used to measure the Healthy Life Style Behaviours.
Study NCT05402943 — intervention group
Intervention type: BEHAVIORAL
Intervention: The Satisfaction Questionnaire for Nursing Care Program for women with Endometriosis.
Description: A questionnaire used to measure the satisfaction levels of women with endometriosis who applied the Nursing Care Program for women with endometriosis.
Study NCT04702373 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: passive range of motion exercise therapy
Description: Systematic flexion-extension with gentle compression at the end of the movement is performed 10 times at the wrist, elbow, shoulder, ankle, knee, and hip joints. Ten repetitions of adduction-abduction are performed at the shoulder and hip joints.
Study NCT05732012 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sexual Health Psychoeducation Program
Description: 62 adolescents were included in the study. Adolescents were assigned to intervention and control groups by randomization using simple numbers table. The intervention group was divided into 3 groups of 10 and included in a six-week psychoeducation program that lasted for one hour once a week, and 55 adolescents completed the program. The data on the sociodemographic characteristics of the adolescents constituting the sample were collected with the Participant Information Form. Data on the effectiveness of the psychoeducation program on sexual health knowledge and attitudes were collected with the Sexual Health Knowledge and Attitude Inventory before the psychoeducation, at the end of the training and at the 3rd month of follow-up.
Study NCT05498545 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: LUCAR-B68 cells product
Description: Before treatment with LUCAR-B68 cells, subjects will receive a conditioning regimen
Study NCT00413101 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: epoetin beta [NeoRecormon]
Description: At a dose to achieve and maintain an Hb level of 120-135g/L
Study NCT04230096 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: low level laser therapy
Description: apply low level laser therapy on buccal surface of maxillary jaw on anterior segment for three minutes at every three weeks in fixed orthodontic patients in their regular follow up visits
Study NCT05726123 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: The Exopulse Mollii Suit on a Fibromyalgia patient
Description: The present study consists of a comparative, randomized, controlled and clinical trial conducted to explore and compare the acute and chronic effects a treatment session with the Exopulse Mollii Suit, a treatment session with the Exopulse Mollii Suit combined with VR and a training session have on a Fibromyalgia patient.
Study NCT05726123 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: The Exopulse Mollii Suit on a Fibromyalgia patient
Description: The present study consists of a comparative, randomized, controlled and clinical trial conducted to explore and compare the acute and chronic effects a treatment session with the Exopulse Mollii Suit, a treatment session with the Exopulse Mollii Suit combined with VR and a training session have on a Fibromyalgia patient.
Study NCT05401773 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Real-time Quaking-Induced Conversion (RT-QuIC)
Description: RT-QuIC is increasingly used as diagnostic tools in synucleinopathies and has shown high sensitivity and specificity for the detection of α-synuclein seeds in CSF and tissue samples, including the olfactory mucosa in different patients' cohorts including Parkinson's patientients, patients with REM sleep behavior disorder (RBD), and patients with dementia with Lewy bodies.
Study NCT06026904 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: transcutaneous auricular vagus nerve stimulation
Description: taVNS was developed as a non-invasive variant of VNS where the vagus nerve is stimulated through the skin of the auricle, which has become a promising avenue for research and, potentially, treatment of various disorders. Commonly, taVNS is applied via the ear targeting the auricular branch of the vagus nerve, where the stimulation elicits far-field potentials. In line with preclinical studies, acute taVNS enhances invigoration of effort and response inhibition capability.
Study NCT06026904 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: transcutaneous auricular vagus nerve stimulation
Description: taVNS was developed as a non-invasive variant of VNS where the vagus nerve is stimulated through the skin of the auricle, which has become a promising avenue for research and, potentially, treatment of various disorders. Commonly, taVNS is applied via the ear targeting the auricular branch of the vagus nerve, where the stimulation elicits far-field potentials. In line with preclinical studies, acute taVNS enhances invigoration of effort and response inhibition capability.
Study NCT06287060 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: strawberry extract.
Description: strawberry has a whitening effect due to its content of ellagic and maleic acids. the presence of acidic components namely ascorbic acid may increase the surface energy by removing the surface debris, thereby allowing the citric and maleic acids to penetrate into tooth surface to remove the surface stains.
Study NCT06287060 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: strawberry extract.
Description: strawberry has a whitening effect due to its content of ellagic and maleic acids. the presence of acidic components namely ascorbic acid may increase the surface energy by removing the surface debris, thereby allowing the citric and maleic acids to penetrate into tooth surface to remove the surface stains.
Study NCT06026891 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MG-K10/Placebo
Description: MG-K10 Humanized Monoclonal Antibody Injection
Study NCT06026891 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: MG-K10/Placebo
Description: MG-K10 Humanized Monoclonal Antibody Injection
Study NCT05728164 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cinematic Simulation
Description: Comprehensive videos from specific films will be selected as films fitting the needs of participants and the established objectives. The films comprehensively develops several characters enriching the values of positive emotions, resilience and empathy. The intervention film videos will be delivered on 5 sessions for each group (2 sessions per week).
Study NCT04869735 — intervention group
Intervention type: OTHER
Intervention: Data collection: DTPolio vaccine delivery
Description: with information about booster vaccination group: Sending of information concerning booster vaccination against DTPolio at 25 years using letters, emails and SMS without information about booster vaccination group: no intervention
Study NCT06178874 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Insulin Glargine
Description: hyperglycemic control
Study NCT06178874 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Insulin Degludec
Description: hyperglycemic control
Study NCT06178874 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Insulin regular
Description: hyperglycemic control
Study NCT04917094 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Compression stocking
Description: A below-the-knee compression stock will be worn daily for 2 weeks from waking up to before sleep.~Bioelectrical impedance will be performed before and 2 weeks after wearing the stocking to assess the total body water content.~Measuring the calf and neck circumference will be done before and after wearing the compression stocking. After 2 weeks, the patient will return back to the clinic for calf and neck circumference measurement.~Sleep test will be done the night before and 2 weeks after wearing the compression stocking. Oxygen Desaturation Index(ODI) will be assessed through a level 4 home sleep apnea testing device.~Patients recruited will have mild excessive to severe excessive daytime sleepiness and/or STOP-Bang score of 3 or more, with underlying conditions such as type II diabetes and hypertensive patients using the Epworth sleepiness scale. Epworth sleepiness scale will be assessed again 2 weeks after to assess for increase sleep efficiency.
Study NCT05897177 — intervention group
Intervention type: BEHAVIORAL
Intervention: Subjective Scale of Stigma and Discrimination (SISD).
Description: Subjective Scale of Stigma and Discrimination (SISD) A sixdimension self-administered scale will be used that included statements with which the participants agreed or disagreed. The scale consists of 23 Likert-type items and responses range from 1 (completely in disagreement) to 5 (completely in agreement), grouped together to represent the six indicators making up this part of the scale
Study NCT05192837 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intensive preoperative smoking cessation counselling
Description: The study intervention consists of an interview by a Tabacco Treatment Specialist (TSS) 4 weeks before surgery with individual counselling and offered nicotine substitution. The intervention meeting is based on the Chronic Care Model (CCM) to improve quality of ambulatory care.~In brief, the intervention includes:~* Informative content about advantages of smoking cessation~* Scheduling service for a motivational interview by a TSS in office to implement a treatment plan~* For participants willing to quit smoking a preoperative quit day will be scheduled after the first intervention meeting 2-3 weeks before surgery~* Patients will be encouraged by a TSS to use nicotine replacement. Bupropion or Vareniclin will be provided on an individual basis~* TSS will schedule repeated follow-up meetings to support smoking abstinence or nicotine reduction before and after surgery for all patients
Study NCT06388551 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY03017
Description: single dose, administered orally
Study NCT06388551 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: LY03017-Placebo
Description: single dose, administered orally
Study NCT05907135 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Beet
Description: Beet-based powder with other ingredients
Study NCT05907135 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo powder.
Study NCT05814120 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: BLS training program
Description: BLS training program was in accordance with the 2020 AHA cardiopulmonary resuscitation (CPR) guidelines. The BLS training program adopts 4D teaching techniques, namely description (Describe), demonstration (Demo), implementation (Do), feedback (Debriefing).
Study NCT05704946 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: THE EFFECT OF LAVENDER INHALATION ON SLEEP QUALITY IN INDIVIDUALS WITH CORONARY HEART DISEASE
Description: The index includes 24 questions that evaluate the quality of sleep and the type and severity of sleep disorders experienced in the last 1 month period. The total score in the index takes a value between 0-21. If the total score is higher than 5, it is interpreted as poor sleep quality.